Exploratory study to evaluate effect of ferric citrate hydrate on oxidative-stress in maintenance hemodialysis patients. - Exploratory study to evaluate effect of ferric citrate hydrate on oxidative-stress.

Fukushima Medical University0 个研究点目标入组 6 人开始时间: 2016年1月22日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients whose serum ferritin level is more than 300 ng/mL according to the laboratory data which is taken without 12 weeks prior to the beginning of the trial. 2) Patients who received intravenous iron agents within 4 weeks prior to the beginning of the trial. 3) Patients who received oral iron agents within 2 weeks before the beginning of the trial. 4) Patients who received blood transfusion therapy within 12 weeks prior to the beginning of the trial. 5) Patients who are pregnant or breastfeeding. 6) Patients with a history of gastrectomy or duodenectomy. 7) Current smokers. 8) Patients with acute or severe chronic inflammatory condition. 9) Patients with active infection. 10) Patients with uncontrolled hypertension or diabetes. 11) Patients with cardiac or cerebrovascular disease. 12) Patients with malignancy (including hematological malignancy), or with a history of malignancy within 5 years prior to registration. 13) Patients judged as inappropriate candidates for the trial by the investigators.

发起方